Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bhisitkul

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab TreatmentLaura Kuehlewein, Laurie Dustin, Min Sagong, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|October 14, 2022
Macular Atrophy Incidence, Progression, and Visual Acuity Effects in 5-Year Treatment of Neovascular Age-Related Macular DegenerationQuintin R Richardson, Youning Zhang, Michael S Deiner, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 9, 2013
Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) filmsDaniel A Bernards, Robert B Bhisitkul, Paula Wynn, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 30, 2024
Subretinal hyperreflective material in regions of atrophy and fibrosis in eyes with neovascular age-related macular degenerationSophiana Lindenberg, Muneeswar G Nittala, Aditya Verma, et al.
Molecular Therapy. Nucleic Acids|August 28, 2019
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal DiseaseYusaku Matsuda, Yosuke Nonaka, Satoshi Futakawa, et al.
Ophthalmology Science|October 6, 2025
In Vivo Comparison of Intracameral and Intravitreal Implantation of a Timolol Maleate Miniaturized Injectable Delivery System DeviceChu Jian Ma, Youning Zhang, Daniel A Bernards, et al.
Eye (London, England)|February 8, 2014
Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008D T Q Barbosa, T S Mendes, H R Cíntron-Colon, et al.
ACS Materials Au|December 13, 2023
Injectable Devices for Delivery of Liquid or Solid Protein FormulationsDaniel A Bernards, Chu Jian Ma, Youning Zhang, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 8, 2019
Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular DeviceKaren E Samy, Yiqi Cao, Jean Kim, et al.
Bioengineering & Translational Medicine|January 26, 2019
Device design methodology and formulation of a protein therapeutic for sustained release intraocular deliveryErica B Schlesinger, Daniel A Bernards, Hunter H Chen, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab TreatmentLaura Kuehlewein, Laurie Dustin, Min Sagong, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|October 14, 2022
Macular Atrophy Incidence, Progression, and Visual Acuity Effects in 5-Year Treatment of Neovascular Age-Related Macular DegenerationQuintin R Richardson, Youning Zhang, Michael S Deiner, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 9, 2013
Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) filmsDaniel A Bernards, Robert B Bhisitkul, Paula Wynn, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 30, 2024
Subretinal hyperreflective material in regions of atrophy and fibrosis in eyes with neovascular age-related macular degenerationSophiana Lindenberg, Muneeswar G Nittala, Aditya Verma, et al.
Molecular Therapy. Nucleic Acids|August 28, 2019
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal DiseaseYusaku Matsuda, Yosuke Nonaka, Satoshi Futakawa, et al.
Ophthalmology Science|October 6, 2025
In Vivo Comparison of Intracameral and Intravitreal Implantation of a Timolol Maleate Miniaturized Injectable Delivery System DeviceChu Jian Ma, Youning Zhang, Daniel A Bernards, et al.
Eye (London, England)|February 8, 2014
Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008D T Q Barbosa, T S Mendes, H R Cíntron-Colon, et al.
ACS Materials Au|December 13, 2023
Injectable Devices for Delivery of Liquid or Solid Protein FormulationsDaniel A Bernards, Chu Jian Ma, Youning Zhang, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 8, 2019
Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular DeviceKaren E Samy, Yiqi Cao, Jean Kim, et al.
Bioengineering & Translational Medicine|January 26, 2019
Device design methodology and formulation of a protein therapeutic for sustained release intraocular deliveryErica B Schlesinger, Daniel A Bernards, Hunter H Chen, et al.
Pageof 6